OXYBUTYNIN CHLORIDE

OXYBUTYNIN CHLORIDE was reported 8884 times

OXYBUTYNIN CHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 114 0.3762
1 FEMALE GENITAL TRACT FISTULA 116 0.0679
2 RADICULOPATHY 120 0.0455
3 PROCTITIS 116 0.0414
4 ANTICHOLINERGIC SYNDROME 51 0.0320
5 CHRONIC SINUSITIS 119 0.0317
6 SMOKE SENSITIVITY 9 0.0292
7 MUSCULAR DYSTROPHY 11 0.0252
8 DELUSION OF GRANDEUR 6 0.0134
9 VAGINAL DISCHARGE 117 0.0116
10 NEUROGENIC BLADDER 24 0.0114
11 ORAL CANDIDIASIS 120 0.0091
12 BLADDER SPASM 17 0.0091
13 MACULAR DEGENERATION 105 0.0088
14 URINE LEUKOCYTE ESTERASE POSITIVE 6 0.0086
15 DEPERSONALISATION 7 0.0084
16 HYPERTONIC BLADDER 22 0.0076
17 STRESS URINARY INCONTINENCE 8 0.0074
18 URGE INCONTINENCE 6 0.0069
19 PARAESTHESIA ORAL 96 0.0066
20 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 7 0.0066
21 EYELID PAIN 13 0.0064
22 INFUSION SITE DISCHARGE 11 0.0063
23 BLADDER OPERATION 7 0.0060
24 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 11 0.0058
25 CLONUS 16 0.0058
26 BLADDER DYSFUNCTION 6 0.0058
27 INFUSION SITE MASS 6 0.0055
28 LUMBAR RADICULOPATHY 6 0.0052
29 CATAPLEXY 7 0.0049
30 BLADDER DISORDER 49 0.0049
31 DISORGANISED SPEECH 9 0.0049
32 FREQUENT BOWEL MOVEMENTS 126 0.0047
33 RENAL ARTERY STENOSIS 6 0.0044
34 ESCHERICHIA URINARY TRACT INFECTION 18 0.0042
35 NONINFECTIVE GINGIVITIS 6 0.0041
36 PERONEAL NERVE PALSY 22 0.0039
37 IMPAIRED SELF-CARE 8 0.0039
38 ESSENTIAL HYPERTENSION 7 0.0038
39 HALLUCINATIONS, MIXED 16 0.0038
40 INFUSION SITE PRURITUS 12 0.0038
41 LIVING IN RESIDENTIAL INSTITUTION 7 0.0037
42 WHITE BLOOD CELLS URINE POSITIVE 7 0.0037
43 NARCOLEPSY 7 0.0037
44 BODY MASS INDEX INCREASED 5 0.0037
45 DECUBITUS ULCER 30 0.0037
46 URINE ANALYSIS ABNORMAL 11 0.0037
47 URINARY INCONTINENCE 107 0.0036
48 WHEELCHAIR USER 16 0.0036
49 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 6 0.0036
50 MICTURITION URGENCY 41 0.0036
51 MUSCLE SPASTICITY 44 0.0036
52 PROCEDURAL PAIN 97 0.0035
53 WALKING AID USER 23 0.0035
54 COLITIS 129 0.0034
55 SEASONAL ALLERGY 48 0.0034
56 MITRAL VALVE DISEASE 6 0.0034
57 HAEMATOLOGICAL INFECTION 8 0.0033
58 NEPHROGENIC ANAEMIA 15 0.0032
59 INFECTED SKIN ULCER 6 0.0032
60 LIP DISORDER 6 0.0032
61 RECTAL HAEMORRHAGE 136 0.0032
62 BLOOD PRESSURE DIASTOLIC ABNORMAL 8 0.0031
63 MULTIPLE SCLEROSIS 147 0.0031
64 INCONTINENCE 32 0.0030
65 SINUS PAIN 7 0.0030
66 TRIGEMINAL NEURALGIA 12 0.0030
67 DECREASED INTEREST 17 0.0029
68 VASCULAR DEVICE INFECTION 13 0.0029
69 POLYMYALGIA RHEUMATICA 9 0.0028
70 BLOOD PRESSURE SYSTOLIC ABNORMAL 7 0.0028
71 HYPERPARATHYROIDISM SECONDARY 7 0.0028
72 INFUSION SITE BRUISING 6 0.0028
73 URINARY TRACT INFECTION BACTERIAL 7 0.0028
74 COLITIS ULCERATIVE 123 0.0027
75 MULTIPLE SCLEROSIS RELAPSE 187 0.0027
76 BLOOD CHLORIDE DECREASED 7 0.0027
77 TEMPERATURE INTOLERANCE 28 0.0027
78 PERSONALITY DISORDER 7 0.0027
79 URINARY TRACT INFECTION 454 0.0027
80 PARANASAL SINUS DISCOMFORT 10 0.0026
81 WOUND COMPLICATION 9 0.0026
82 CYSTITIS 81 0.0025
83 RED BLOOD CELL COUNT INCREASED 7 0.0025
84 INFUSION SITE ERYTHEMA 21 0.0025
85 OXYGEN SATURATION ABNORMAL 7 0.0025
86 POSTURE ABNORMAL 8 0.0025
87 DRY MOUTH 199 0.0025
88 PRODUCT DOSE OMISSION IN ERROR 69 0.0024
89 MULTIPLE ALLERGIES 19 0.0024
90 SCOLIOSIS 15 0.0024
91 HAEMATOCHEZIA 133 0.0024
92 THERAPEUTIC AGENT TOXICITY 8 0.0024
93 BALANCE DISORDER 206 0.0024
94 CEREBRAL ATROPHY 9 0.0023
95 HYPERPHAGIA 9 0.0023
96 VITAMIN D DEFICIENCY 22 0.0023
97 BLOOD BLISTER 7 0.0022
98 ENURESIS 9 0.0022
99 SHOULDER ARTHROPLASTY 6 0.0022
100 INFUSION SITE SWELLING 14 0.0022
101 VITAMIN B12 DEFICIENCY 9 0.0022
102 HAEMOGLOBIN INCREASED 10 0.0022
103 INFUSION SITE PAIN 28 0.0022
104 HYPERACUSIS 8 0.0021
105 ELECTRIC SHOCK SENSATION 6 0.0021
106 NOCTURIA 26 0.0021
107 VARICOSE VEIN 11 0.0021
108 INFUSION SITE HAEMORRHAGE 7 0.0021
109 SKIN ABRASION 10 0.0021
110 POLLAKIURIA 88 0.0021
111 BLOOD IRON DECREASED 25 0.0021
112 PRE-EXISTING CONDITION IMPROVED 13 0.0021
113 FAECAL INCONTINENCE 10 0.0021
114 NASAL DRYNESS 13 0.0021
115 BRADYKINESIA 12 0.0020
116 RHINITIS ALLERGIC 9 0.0020
117 AORTIC STENOSIS 7 0.0020
118 JAW DISORDER 11 0.0020
119 CAROTID ARTERY STENOSIS 7 0.0020
120 ANKLE FRACTURE 31 0.0020
121 URINARY TRACT DISORDER 9 0.0020
122 EYE PAIN 112 0.0020
123 REBOUND ACID HYPERSECRETION 6 0.0020
124 FUNGAL SKIN INFECTION 8 0.0020
125 URINE ABNORMALITY 9 0.0020
126 SKIN WEEPING 7 0.0020
127 URINARY RETENTION 65 0.0019
128 PERIPHERAL VASCULAR DISORDER 10 0.0019
129 SLEEP APNOEA SYNDROME 37 0.0019
130 CONCUSSION 15 0.0019
131 SKIN LACERATION 21 0.0019
132 RED CELL DISTRIBUTION WIDTH INCREASED 8 0.0019
133 CENTRAL NERVOUS SYSTEM LESION 26 0.0019
134 ANAL INCONTINENCE 17 0.0019
135 INFUSION RELATED REACTION 125 0.0019
136 INTERVERTEBRAL DISC DISORDER 8 0.0019
137 CONSTIPATION 407 0.0019
138 GAIT DISTURBANCE 356 0.0019
139 DYSPEPSIA 182 0.0018
140 BACK DISORDER 30 0.0018
141 THERAPY CESSATION 94 0.0018
142 GASTRIC INFECTION 7 0.0018
143 DIVERTICULUM 13 0.0018
144 NEPHROLITHIASIS 83 0.0018
145 FALL 589 0.0018
146 NEURALGIA 43 0.0018
147 OBSTRUCTION 7 0.0018
148 HEAD INJURY 55 0.0017
149 FUNCTIONAL GASTROINTESTINAL DISORDER 6 0.0017
150 LYMPHOEDEMA 12 0.0017
151 BLOOD CREATININE ABNORMAL 6 0.0017
152 UROSEPSIS 16 0.0017
153 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 121 0.0017
154 LYMPHOCYTE COUNT DECREASED 30 0.0017
155 JOINT INJURY 36 0.0017
156 KIDNEY INFECTION 33 0.0017
157 DYSGRAPHIA 11 0.0017
158 TOOTH INFECTION 22 0.0017
159 MONOCYTE COUNT INCREASED 6 0.0017
160 LIMB DISCOMFORT 51 0.0016
161 NONSPECIFIC REACTION 9 0.0016
162 HYPERSOMNIA 47 0.0016
163 HOSPICE CARE 16 0.0016
164 CHAPPED LIPS 7 0.0016
165 INFUSION SITE EXTRAVASATION 10 0.0016
166 ONYCHOCLASIS 11 0.0016
167 MELANOCYTIC NAEVUS 7 0.0016
168 MENTAL STATUS CHANGES 44 0.0016
169 LOSS OF CONTROL OF LEGS 6 0.0016
170 LIMB INJURY 43 0.0016
171 FACE INJURY 6 0.0016
172 GRANULOCYTOPENIA 9 0.0016
173 TOOTH ABSCESS 16 0.0016
174 CARPAL TUNNEL SYNDROME 22 0.0016
175 COMMUNICATION DISORDER 6 0.0016
176 THYROID MASS 6 0.0016
177 SOMNAMBULISM 10 0.0015
178 INCREASED TENDENCY TO BRUISE 14 0.0015
179 HALLUCINATION, VISUAL 32 0.0015
180 MUSCULAR WEAKNESS 172 0.0015
181 LOCALISED OEDEMA 7 0.0015
182 FAECES SOFT 11 0.0015
183 RENAL CYST 12 0.0015
184 DYSSTASIA 44 0.0015
185 DELIRIUM 52 0.0015
186 GASTROENTERITIS VIRAL 27 0.0015
187 EMPHYSEMA 15 0.0015
188 POSTOPERATIVE WOUND INFECTION 10 0.0015
189 SPINAL OSTEOARTHRITIS 13 0.0015
190 TRIGGER FINGER 6 0.0015
191 GOITRE 6 0.0015
192 MENISCUS INJURY 9 0.0015
193 HAEMATOCRIT DECREASED 29 0.0015
194 BLOOD PRESSURE ABNORMAL 29 0.0015
195 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 76 0.0015
196 LARGE INTESTINE POLYP 10 0.0014
197 RESTLESS LEGS SYNDROME 26 0.0014
198 SLEEP TERROR 6 0.0014
199 LIP OEDEMA 6 0.0014
200 MUSCLE FATIGUE 6 0.0014
201 CHRONIC KIDNEY DISEASE 107 0.0014
202 FLUSHING 143 0.0014
203 VITAMIN D DECREASED 12 0.0014
204 PRODUCTIVE COUGH 67 0.0014
205 LEFT VENTRICULAR HYPERTROPHY 6 0.0014
206 PRODUCT ADMINISTRATION INTERRUPTED 11 0.0014
207 INCOHERENT 9 0.0014
208 ORAL PAIN 31 0.0014
209 VULVOVAGINAL PRURITUS 7 0.0014
210 SKIN FISSURES 27 0.0014
211 OBESITY 22 0.0014
212 IMMOBILE 6 0.0014
213 SPINAL DISORDER 13 0.0014
214 ONYCHOMYCOSIS 6 0.0014
215 INITIAL INSOMNIA 14 0.0014
216 RED BLOOD CELL COUNT DECREASED 39 0.0014
217 COORDINATION ABNORMAL 19 0.0014
218 CEREBRAL ISCHAEMIA 7 0.0014
219 DEMENTIA 38 0.0014
220 DENTAL CARIES 15 0.0014
221 UPPER LIMB FRACTURE 27 0.0014
222 BLOOD PRESSURE DIASTOLIC DECREASED 10 0.0014
223 GLUCOSE TOLERANCE IMPAIRED 8 0.0014
224 AFFECT LABILITY 13 0.0013
225 SINUS HEADACHE 8 0.0013
226 HYDRONEPHROSIS 10 0.0013
227 UPPER-AIRWAY COUGH SYNDROME 11 0.0013
228 WRIST FRACTURE 16 0.0013
229 WEIGHT DECREASED 371 0.0013
230 BLOOD THYROID STIMULATING HORMONE DECREASED 6 0.0013
231 CLOSTRIDIUM DIFFICILE COLITIS 14 0.0013
232 MEMORY IMPAIRMENT 181 0.0013
233 DERMATITIS CONTACT 15 0.0013
234 EAR DISORDER 6 0.0013
235 INSURANCE ISSUE 20 0.0013
236 COMPRESSION FRACTURE 7 0.0013
237 BOWEL MOVEMENT IRREGULARITY 10 0.0013
238 RESPIRATORY TRACT INFECTION 34 0.0013
239 EYE OPERATION 6 0.0013
240 DECREASED ACTIVITY 14 0.0013
241 THYROID DISORDER 20 0.0013
242 INTERVERTEBRAL DISC DEGENERATION 12 0.0013
243 HIP SURGERY 7 0.0013
244 PELVIC FRACTURE 10 0.0013
245 HIP FRACTURE 41 0.0013
246 BLOOD MAGNESIUM DECREASED 11 0.0013
247 ASTHENOPIA 7 0.0013
248 SPINAL COLUMN STENOSIS 6 0.0013
249 HAND FRACTURE 9 0.0013
250 CELLULITIS 64 0.0013
251 NEUTROPHIL COUNT INCREASED 13 0.0013
252 PYELONEPHRITIS 11 0.0013
253 NASAL DISCOMFORT 10 0.0013
254 MUSCULOSKELETAL DISORDER 24 0.0013
255 TRICUSPID VALVE INCOMPETENCE 10 0.0013
256 ENDOMETRIOSIS 6 0.0013
257 UPPER RESPIRATORY TRACT INFECTION 58 0.0013
258 FOREIGN BODY SENSATION IN EYES 8 0.0013
259 ABASIA 31 0.0013
260 WHITE BLOOD CELL COUNT ABNORMAL 8 0.0013
261 IMPAIRED GASTRIC EMPTYING 17 0.0012
262 SENSORY LOSS 10 0.0012
263 FULL BLOOD COUNT DECREASED 25 0.0012
264 BURSITIS 15 0.0012
265 GAIT INABILITY 41 0.0012
266 DELUSION 19 0.0012
267 POLYP 8 0.0012
268 HOT FLUSH 92 0.0012
269 BLOOD SODIUM DECREASED 23 0.0012
270 MUSCULOSKELETAL DISCOMFORT 21 0.0012
271 LOWER GASTROINTESTINAL HAEMORRHAGE 9 0.0012
272 BODY HEIGHT DECREASED 13 0.0012
273 SKIN HAEMORRHAGE 18 0.0012
274 MOBILITY DECREASED 87 0.0012
275 PRODUCT DOSE OMISSION 79 0.0012
276 HALLUCINATION 91 0.0012
277 APPETITE DISORDER 8 0.0012
278 SKIN WARM 7 0.0012
279 HYPOAESTHESIA 180 0.0012
280 VEIN DISORDER 6 0.0012
281 PRODUCT DOSE OMISSION ISSUE 350 0.0012
282 ECONOMIC PROBLEM 18 0.0012
283 ATTENTION DEFICIT HYPERACTIVITY DISORDER 5 0.0012
284 DRUG TOLERANCE 6 0.0012
285 PRODUCT DISTRIBUTION ISSUE 11 0.0012
286 DYSLIPIDAEMIA 6 0.0012
287 ANAEMIA 225 0.0012
288 BRONCHITIS 87 0.0012
289 CONTUSION 113 0.0012
290 ABSCESS LIMB 5 0.0012
291 ACCIDENT 14 0.0012
292 PRODUCT COLOUR ISSUE 6 0.0012
293 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 56 0.0012
294 BLOOD POTASSIUM DECREASED 35 0.0012
295 BENIGN PROSTATIC HYPERPLASIA 6 0.0012
296 END STAGE RENAL DISEASE 21 0.0012
297 ORTHOSTATIC HYPOTENSION 20 0.0011
298 SPINAL FRACTURE 23 0.0011
299 VULVOVAGINAL BURNING SENSATION 7 0.0011
300 LOWER LIMB FRACTURE 22 0.0011
301 AFFECTIVE DISORDER 9 0.0011
302 INTERVERTEBRAL DISC PROTRUSION 25 0.0011
303 GASTROOESOPHAGEAL REFLUX DISEASE 92 0.0011
304 DYSURIA 42 0.0011
305 ATELECTASIS 11 0.0011
306 BLOOD ALBUMIN DECREASED 9 0.0011
307 DIZZINESS POSTURAL 11 0.0011
308 CONFUSIONAL STATE 183 0.0011
309 BLOOD PRESSURE SYSTOLIC INCREASED 22 0.0011
310 CANDIDA INFECTION 19 0.0011
311 ABNORMAL DREAMS 31 0.0011
312 DECREASED IMMUNE RESPONSIVENESS 11 0.0011
313 THIRST 20 0.0011
314 INFLUENZA LIKE ILLNESS 92 0.0011
315 GASTROINTESTINAL INFECTION 10 0.0011
316 COGNITIVE DISORDER 52 0.0011
317 GINGIVITIS 6 0.0011
318 VISUAL FIELD DEFECT 8 0.0011
319 POST PROCEDURAL INFECTION 9 0.0011
320 BLOOD URINE PRESENT 21 0.0011
321 BIPOLAR DISORDER 12 0.0011
322 HYPOKINESIA 16 0.0011
323 ROAD TRAFFIC ACCIDENT 46 0.0011
324 ABDOMINAL HERNIA 5 0.0011
325 FAECALOMA 6 0.0011
326 MAJOR DEPRESSION 8 0.0011
327 OXYGEN SATURATION DECREASED 61 0.0011
328 PSYCHIATRIC SYMPTOM 8 0.0011
329 BLOOD PRESSURE FLUCTUATION 26 0.0011
330 CARDIAC FLUTTER 7 0.0011
331 HIATUS HERNIA 14 0.0011
332 FUNGAL INFECTION 36 0.0011
333 MOTOR DYSFUNCTION 11 0.0011
334 ILLNESS 111 0.0011
335 REFUSAL OF TREATMENT BY PATIENT 7 0.0011
336 ASTHENIA 403 0.0011
337 NEPHROPATHY 10 0.0011
338 HYPOGAMMAGLOBULINAEMIA 7 0.0011
339 BEDRIDDEN 14 0.0011
340 PHOTOPHOBIA 20 0.0011
341 PERIORBITAL SWELLING 6 0.0011
342 APHASIA 32 0.0011
343 DEPRESSED MOOD 56 0.0011
344 CARDIAC FAILURE CONGESTIVE 85 0.0011
345 ARTERIOSCLEROSIS CORONARY ARTERY 7 0.0011
346 NECK PAIN 59 0.0011
347 OSTEOMYELITIS 19 0.0010
348 VISUAL DISTURBANCE 6 0.0010
349 BRONCHIECTASIS 7 0.0010
350 DISORIENTATION 41 0.0010
351 SINUSITIS 106 0.0010
352 RESPIRATORY SYNCYTIAL VIRUS INFECTION 9 0.0010
353 RALES 6 0.0010
354 EAR PAIN 20 0.0010
355 HYPOVOLAEMIA 6 0.0010
356 HEART RATE DECREASED 36 0.0010
357 HAEMORRHAGIC STROKE 8 0.0010
358 NIGHT SWEATS 33 0.0010
359 POOR QUALITY SLEEP 22 0.0010
360 BRAIN FOG 16 0.0010
361 COVID-19 179 0.0010
362 MIDDLE INSOMNIA 19 0.0010
363 DROOLING 7 0.0010
364 PULMONARY HYPERTENSION 21 0.0010
365 CARDIAC PACEMAKER INSERTION 6 0.0010
366 PERIPHERAL SWELLING 155 0.0010
367 PRESCRIBED UNDERDOSE 20 0.0010
368 FOOT FRACTURE 19 0.0010
369 DIPLOPIA 26 0.0010
370 STAPHYLOCOCCAL INFECTION 33 0.0010
371 TOOTHACHE 18 0.0010
372 LOCALISED INFECTION 24 0.0010
373 FEEDING DISORDER 20 0.0010
374 TASTE DISORDER 20 0.0010
375 EXOSTOSIS 9 0.0010
376 DRY THROAT 10 0.0010
377 VISION BLURRED 135 0.0010
378 SUBSTANCE ABUSE 8 0.0010
379 SKIN INFECTION 11 0.0010
380 OEDEMA 53 0.0010
381 BACK PAIN 227 0.0010
382 ABDOMINAL PAIN 227 0.0010
383 IRON DEFICIENCY ANAEMIA 9 0.0010
384 FLATULENCE 55 0.0010
385 CHOLANGITIS 6 0.0010
386 TONGUE DISORDER 7 0.0010
387 OSTEOARTHRITIS 41 0.0010
388 SINUS CONGESTION 13 0.0010
389 CLOSTRIDIUM DIFFICILE INFECTION 21 0.0010
390 DRY EYE 48 0.0010
391 DYSARTHRIA 36 0.0010
392 DYSPNOEA EXERTIONAL 36 0.0010
393 FATIGUE 744 0.0010
394 AMNESIA 62 0.0010
395 MULTIPLE INJURIES 6 0.0010
396 DEHYDRATION 127 0.0010
397 DEPRESSION 216 0.0009
398 SPUTUM DISCOLOURED 9 0.0009
399 DYSPHAGIA 90 0.0009
400 PERIPHERAL COLDNESS 13 0.0009
401 NEUROPATHY PERIPHERAL 90 0.0009
402 FULL BLOOD COUNT ABNORMAL 10 0.0009
403 DRUG EFFECT LESS THAN EXPECTED 14 0.0009
404 TOOTH DISORDER 21 0.0009
405 INCREASED APPETITE 18 0.0009
406 PRODUCT ADMINISTRATION ERROR 19 0.0009
407 IMMUNODEFICIENCY 14 0.0009
408 ACUTE RESPIRATORY FAILURE 18 0.0009
409 PARAESTHESIA 147 0.0009
410 MOVEMENT DISORDER 30 0.0009
411 IRRITABLE BOWEL SYNDROME 20 0.0009
412 SOMNOLENCE 187 0.0009
413 CARDIAC MURMUR 8 0.0009
414 ERYTHEMA 190 0.0009
415 BEHAVIOUR DISORDER 5 0.0009
416 RIB FRACTURE 19 0.0009
417 OSTEOPENIA 14 0.0009
418 HYPERTHERMIA 7 0.0009
419 COUGH 257 0.0009
420 SPEECH DISORDER 48 0.0009
421 KNEE OPERATION 9 0.0009
422 THERAPEUTIC RESPONSE UNEXPECTED 41 0.0009
423 MUSCULOSKELETAL STIFFNESS 80 0.0009
424 MIGRAINE 87 0.0009
425 HEADACHE 571 0.0009
426 SUBDURAL HAEMATOMA 13 0.0009
427 FIBROMYALGIA 22 0.0009
428 LOW DENSITY LIPOPROTEIN INCREASED 7 0.0009
429 FOOT DEFORMITY 10 0.0009
430 DIVERTICULITIS 25 0.0009
431 EAR INFECTION 24 0.0009
432 BLOOD CHOLESTEROL INCREASED 42 0.0009
433 DIZZINESS 448 0.0009
434 HAEMOGLOBIN DECREASED 92 0.0009
435 BLOOD UREA INCREASED 15 0.0009
436 POST-TRAUMATIC STRESS DISORDER 6 0.0009
437 MUSCLE SPASMS 164 0.0009
438 SNEEZING 20 0.0009
439 RETCHING 19 0.0009
440 PNEUMONIA 288 0.0009
441 COLITIS ISCHAEMIC 6 0.0009
442 VERTIGO 54 0.0009
443 FLUID RETENTION 45 0.0009
444 SLUGGISHNESS 9 0.0009
445 LABORATORY TEST ABNORMAL 26 0.0009
446 GINGIVAL PAIN 7 0.0009
447 HERNIA 17 0.0009
448 ARTHRITIS 69 0.0009
449 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 9 0.0009
450 ABDOMINAL DISCOMFORT 147 0.0009
451 ORAL HERPES 17 0.0009
452 SURGERY 51 0.0009
453 THROAT IRRITATION 39 0.0009
454 MUSCLE ATROPHY 11 0.0009
455 RHINITIS 7 0.0009
456 GRAND MAL CONVULSION 8 0.0009
457 OEDEMA PERIPHERAL 105 0.0009
458 WHITE BLOOD CELL COUNT INCREASED 33 0.0009
459 EXTRASYSTOLES 6 0.0009
460 KNEE ARTHROPLASTY 18 0.0009
461 SCRATCH 9 0.0009
462 HERPES ZOSTER 49 0.0009
463 DEVICE OCCLUSION 12 0.0009
464 JOINT DISLOCATION 9 0.0009
465 BLINDNESS UNILATERAL 12 0.0008
466 COVID-19 PNEUMONIA 10 0.0008
467 THERMAL BURN 6 0.0008
468 PRODUCT SUPPLY ISSUE 6 0.0008
469 MUSCULOSKELETAL CHEST PAIN 13 0.0008
470 HYPERLIPIDAEMIA 10 0.0008
471 MUSCLE RIGIDITY 10 0.0008
472 FEELING ABNORMAL 199 0.0008
473 BACK INJURY 9 0.0008
474 LACRIMATION INCREASED 25 0.0008
475 OSTEOPOROSIS 34 0.0008
476 HEMIPARESIS 14 0.0008
477 EYE HAEMORRHAGE 11 0.0008
478 GASTROENTERITIS 12 0.0008
479 ASPIRATION 9 0.0008
480 ATRIAL FIBRILLATION 80 0.0008
481 EYE DISORDER 27 0.0008
482 JOINT RANGE OF MOTION DECREASED 11 0.0008
483 PHARYNGEAL SWELLING 8 0.0008
484 ULCER 13 0.0008
485 INFLUENZA 91 0.0008
486 DISTURBANCE IN ATTENTION 44 0.0008
487 RENAL TUBULAR NECROSIS 8 0.0008
488 VITREOUS FLOATERS 8 0.0008
489 GLOMERULAR FILTRATION RATE DECREASED 10 0.0008
490 DRUG INTERACTION 129 0.0008
491 SKIN ULCER 21 0.0008
492 CEREBRAL DISORDER 6 0.0008
493 BLINDNESS 33 0.0008
494 ARTHROPOD BITE 6 0.0008
495 SINUS DISORDER 16 0.0008
496 THINKING ABNORMAL 15 0.0008
497 DYSPHONIA 47 0.0008
498 PAIN 493 0.0008
499 DIARRHOEA 518 0.0008
500 MUSCLE TIGHTNESS 13 0.0008
501 OCULAR DISCOMFORT 9 0.0008
502 TREMOR 133 0.0008
503 SALIVARY HYPERSECRETION 8 0.0008
504 CHEST PAIN 148 0.0008
505 EYE INFECTION 9 0.0008
506 HEART RATE IRREGULAR 18 0.0008
507 DECREASED APPETITE 185 0.0008
508 PYREXIA 275 0.0008
509 WHITE BLOOD CELL COUNT DECREASED 86 0.0008
510 CORONARY ARTERY DISEASE 24 0.0008
511 LUNG INFILTRATION 7 0.0008
512 IMPAIRED DRIVING ABILITY 9 0.0008
513 BLOOD COUNT ABNORMAL 12 0.0008
514 CATARACT 47 0.0008
515 LIPASE INCREASED 6 0.0008
516 BLOOD TEST ABNORMAL 11 0.0008
517 HYPOTHYROIDISM 25 0.0008
518 HYPOPHAGIA 20 0.0008
519 NAUSEA 619 0.0008
520 LIP SWELLING 26 0.0008
521 DEVICE RELATED INFECTION 12 0.0008
522 BLOOD PRESSURE INCREASED 119 0.0008
523 INSOMNIA 207 0.0008
524 CHILLS 91 0.0008
525 ATRIOVENTRICULAR BLOCK 6 0.0008
526 EYE DISCHARGE 8 0.0008
527 SWOLLEN TONGUE 24 0.0008
528 PETECHIAE 8 0.0008
529 NASAL CONGESTION 45 0.0008
530 JOINT STIFFNESS 20 0.0008
531 SEPSIS 85 0.0008
532 PRODUCT USE COMPLAINT 12 0.0008
533 PULMONARY CONGESTION 10 0.0008
534 THROMBOSIS 61 0.0008
535 BLOOD GLUCOSE ABNORMAL 14 0.0008
536 LOSS OF CONSCIOUSNESS 97 0.0008
537 INFECTION 109 0.0008
538 CHROMATURIA 17 0.0008
539 SCIATICA 12 0.0008
540 EATING DISORDER 16 0.0008
541 WOUND 21 0.0008
542 VIRAL INFECTION 25 0.0008
543 MALAISE 329 0.0007
544 BLOOD DISORDER 6 0.0007
545 OBSESSIVE-COMPULSIVE DISORDER 6 0.0007
546 PRODUCT AVAILABILITY ISSUE 17 0.0007
547 HEREDITARY ANGIOEDEMA 8 0.0007
548 OROPHARYNGEAL PAIN 69 0.0007
549 STENT PLACEMENT 6 0.0007
550 SQUAMOUS CELL CARCINOMA 7 0.0007
551 INTESTINAL OBSTRUCTION 28 0.0007
552 FEMUR FRACTURE 23 0.0007
553 FRUSTRATION TOLERANCE DECREASED 6 0.0007
554 SCHIZOPHRENIA 9 0.0007
555 ABDOMINAL PAIN UPPER 152 0.0007
556 NO THERAPEUTIC RESPONSE 9 0.0007
557 BLOOD PRESSURE DECREASED 49 0.0007
558 BODY TEMPERATURE INCREASED 15 0.0007
559 POLYURIA 6 0.0007
560 NASOPHARYNGITIS 135 0.0007
561 ABNORMAL FAECES 6 0.0007
562 ABNORMAL BEHAVIOUR 29 0.0007
563 CHOLELITHIASIS 24 0.0007
564 SMALL INTESTINAL OBSTRUCTION 9 0.0007
565 SPINAL OPERATION 9 0.0007
566 SKIN LESION 20 0.0007
567 GASTRIC DISORDER 25 0.0007
568 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 6 0.0007
569 TOOTH FRACTURE 8 0.0007
570 PHARYNGITIS 9 0.0007
571 STOMATITIS 44 0.0007
572 ACUTE KIDNEY INJURY 111 0.0007
573 PRESCRIBED OVERDOSE 14 0.0007
574 ARTHROPATHY 40 0.0007
575 APHONIA 10 0.0007
576 OCULAR HYPERAEMIA 34 0.0007
577 PAIN IN EXTREMITY 211 0.0007
578 ANXIETY 203 0.0007
579 HYPERTENSION 151 0.0007
580 RESTLESSNESS 26 0.0007
581 RENAL DISORDER 33 0.0007
582 ACTIVITIES OF DAILY LIVING IMPAIRED 14 0.0007
583 MITRAL VALVE INCOMPETENCE 8 0.0007
584 SCAB 8 0.0007
585 CHOLECYSTECTOMY 8 0.0007
586 OVARIAN CYST 7 0.0007
587 PSEUDOMONAS INFECTION 6 0.0007
588 BURNING SENSATION 49 0.0007
589 UNRESPONSIVE TO STIMULI 18 0.0007
590 VISUAL IMPAIRMENT 86 0.0007
591 PNEUMOTHORAX 11 0.0007
592 THERAPEUTIC RESPONSE SHORTENED 23 0.0007
593 RENAL FAILURE 92 0.0007
594 RESPIRATORY TRACT CONGESTION 11 0.0007
595 HALLUCINATION, AUDITORY 11 0.0007
596 MOOD SWINGS 22 0.0007
597 NODULE 9 0.0007
598 PRURITUS 264 0.0007
599 RASH MACULAR 24 0.0007
600 URINE OUTPUT DECREASED 6 0.0007
601 SEIZURE 79 0.0007
602 DRY SKIN 91 0.0007
603 ABDOMINAL DISTENSION 71 0.0007
604 SYNCOPE 68 0.0007
605 EYE IRRITATION 39 0.0007
606 RESPIRATORY RATE INCREASED 6 0.0007
607 TINNITUS 31 0.0007
608 PULMONARY MASS 10 0.0007
609 CONDITION AGGRAVATED 204 0.0007
610 IMPAIRED HEALING 22 0.0007
611 MANIA 11 0.0007
612 EPISTAXIS 50 0.0007
613 HAEMORRHOIDS 13 0.0007
614 INTENTIONAL DOSE OMISSION 19 0.0007
615 DYSKINESIA 27 0.0007
616 LIP DRY 6 0.0007
617 MENTAL IMPAIRMENT 16 0.0007
618 ARTHRALGIA 273 0.0007
619 PROSTATIC SPECIFIC ANTIGEN INCREASED 9 0.0007
620 RETINAL DETACHMENT 6 0.0007
621 WEIGHT INCREASED 146 0.0007
622 SLEEP DISORDER 46 0.0007
623 HYPOACUSIS 28 0.0006
624 NERVE COMPRESSION 6 0.0006
625 RHINORRHOEA 42 0.0006
626 CONJUNCTIVITIS 12 0.0006
627 FEELING COLD 18 0.0006
628 APHTHOUS ULCER 5 0.0006
629 MASS 9 0.0006
630 THERAPY INTERRUPTED 46 0.0006
631 EJECTION FRACTION DECREASED 10 0.0006
632 BACTERIAL INFECTION 12 0.0006
633 HYPOTENSION 129 0.0006
634 DIABETES MELLITUS 49 0.0006
635 SCAR 11 0.0006
636 FLANK PAIN 6 0.0006
637 LACERATION 6 0.0006
638 ASTHMA 72 0.0006
639 FEELING HOT 39 0.0006
640 ARTERIAL OCCLUSIVE DISEASE 5 0.0006
641 PAIN IN JAW 18 0.0006
642 RESPIRATORY DISORDER 19 0.0006
643 RED BLOOD CELL SEDIMENTATION RATE INCREASED 7 0.0006
644 ALOPECIA 124 0.0006
645 GASTRIC ULCER 12 0.0006
646 CARDIAC DISORDER 59 0.0006
647 FEELING JITTERY 12 0.0006
648 TOOTH LOSS 13 0.0006
649 SEROTONIN SYNDROME 12 0.0006
650 COLD SWEAT 11 0.0006
651 THERAPY NON-RESPONDER 28 0.0006
652 TRANSIENT ISCHAEMIC ATTACK 21 0.0006
653 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 112 0.0006
654 PULMONARY ARTERIAL HYPERTENSION 9 0.0006
655 MENTAL DISORDER 27 0.0006
656 PLATELET COUNT DECREASED 66 0.0006
657 DRUG DOSE OMISSION 102 0.0006
658 APATHY 9 0.0006
659 SKIN EXFOLIATION 52 0.0006
660 BLOOD POTASSIUM INCREASED 10 0.0006
661 HEART RATE INCREASED 61 0.0006
662 ADVERSE DRUG REACTION 55 0.0006
663 DEAFNESS 16 0.0006
664 ECZEMA 32 0.0006
665 WHEEZING 36 0.0006
666 NIGHTMARE 21 0.0006
667 LIGAMENT SPRAIN 6 0.0006
668 RENAL INJURY 18 0.0006
669 SARS-COV-2 TEST POSITIVE 8 0.0006
670 PHOTOSENSITIVITY REACTION 10 0.0006
671 BLOOD ALKALINE PHOSPHATASE INCREASED 15 0.0006
672 PANIC ATTACK 22 0.0006
673 ELECTROLYTE IMBALANCE 7 0.0006
674 PNEUMONIA ASPIRATION 15 0.0006
675 SWELLING 56 0.0006
676 VOMITING 281 0.0006
677 ATAXIA 7 0.0006
678 DRUG TOXICITY 8 0.0006
679 TUBULOINTERSTITIAL NEPHRITIS 11 0.0006
680 HYPOKALAEMIA 27 0.0006
681 DYSPNOEA 331 0.0006
682 BLOOD GLUCOSE DECREASED 28 0.0006
683 PULMONARY OEDEMA 26 0.0006
684 POOR VENOUS ACCESS 6 0.0006
685 VENTRICULAR EXTRASYSTOLES 6 0.0006
686 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 41 0.0006
687 NERVOUSNESS 30 0.0006
688 RASH PRURITIC 31 0.0006
689 JOINT SWELLING 69 0.0006
690 HYPERSENSITIVITY 106 0.0006
691 ANHEDONIA 15 0.0006
692 INJECTION SITE DISCOMFORT 6 0.0006
693 BLISTER 32 0.0006
694 CARDIOMEGALY 7 0.0006
695 LYMPHOPENIA 8 0.0006
696 HEAD DISCOMFORT 10 0.0006
697 EYE SWELLING 21 0.0006
698 ABSCESS 9 0.0006
699 CYST 7 0.0006
700 BREAST PAIN 6 0.0006
701 PERICARDIAL EFFUSION 13 0.0006
702 AGEUSIA 14 0.0006
703 SECRETION DISCHARGE 7 0.0006
704 PARALYSIS 8 0.0006
705 SKIN CANCER 12 0.0006
706 GOUT 10 0.0006
707 DRUG EFFECT DECREASED 30 0.0006
708 CHEST DISCOMFORT 57 0.0006
709 DISABILITY 11 0.0006
710 LETHARGY 32 0.0006
711 HAEMATURIA 19 0.0006
712 DEEP VEIN THROMBOSIS 36 0.0006
713 MUSCULOSKELETAL PAIN 29 0.0006
714 FAECES DISCOLOURED 12 0.0006
715 OESOPHAGITIS 6 0.0005
716 INTENTIONAL PRODUCT MISUSE 48 0.0005
717 WOUND INFECTION 6 0.0005
718 MYALGIA 93 0.0005
719 BONE PAIN 32 0.0005
720 GASTROINTESTINAL PAIN 6 0.0005
721 ANOREXIA 7 0.0005
722 CEREBROVASCULAR ACCIDENT 92 0.0005
723 CARDIOMYOPATHY 8 0.0005
724 EXPOSURE VIA SKIN CONTACT 14 0.0005
725 HYPERTENSIVE CRISIS 6 0.0005
726 PLATELET COUNT INCREASED 7 0.0005
727 DRUG INEFFECTIVE 704 0.0005
728 HOSPITALISATION 82 0.0005
729 BLOOD CALCIUM DECREASED 6 0.0005
730 HYPONATRAEMIA 30 0.0005
731 HEPATIC CIRRHOSIS 10 0.0005
732 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 9 0.0005
733 UNEVALUABLE EVENT 40 0.0005
734 HEPATIC ENZYME INCREASED 36 0.0005
735 INTERNAL HAEMORRHAGE 6 0.0005
736 DERMATITIS 11 0.0005
737 DYSGEUSIA 39 0.0005
738 CRYING 19 0.0005
739 MALIGNANT MELANOMA 7 0.0005
740 HIP ARTHROPLASTY 8 0.0005
741 SKIN DISCOLOURATION 24 0.0005
742 PARANOIA 9 0.0005
743 HYPERGLYCAEMIA 19 0.0005
744 TENDONITIS 8 0.0005
745 LIVER FUNCTION TEST ABNORMAL 15 0.0005
746 POST PROCEDURAL HAEMORRHAGE 6 0.0005
747 INJECTION SITE BRUISING 41 0.0005
748 HYPERKALAEMIA 18 0.0005
749 BRADYCARDIA 27 0.0005
750 BACTERAEMIA 6 0.0005
751 BLOOD CREATININE INCREASED 33 0.0005
752 TYPE 2 DIABETES MELLITUS 17 0.0005
753 GALLBLADDER DISORDER 9 0.0005
754 INFLAMMATION 26 0.0005
755 LEUKOCYTOSIS 9 0.0005
756 PRODUCT PHYSICAL ISSUE 10 0.0005
757 PALPITATIONS 58 0.0005
758 ADRENAL INSUFFICIENCY 6 0.0005
759 ILL-DEFINED DISORDER 30 0.0005
760 HEPATOCELLULAR INJURY 7 0.0005
761 TREATMENT NONCOMPLIANCE 27 0.0005
762 ACCIDENTAL OVERDOSE 18 0.0005
763 BRONCHOSPASM 7 0.0005
764 PLASMA CELL MYELOMA 19 0.0005
765 IMPAIRED QUALITY OF LIFE 7 0.0005
766 DRUG INTOLERANCE 47 0.0005
767 TENDON RUPTURE 6 0.0005
768 RASH 211 0.0005
769 DRUG LEVEL INCREASED 8 0.0005
770 THROMBOCYTOPENIA 54 0.0005
771 IRRITABILITY 29 0.0005
772 HAIR COLOUR CHANGES 6 0.0005
773 TOOTH EXTRACTION 6 0.0005
774 COMPLICATION ASSOCIATED WITH DEVICE 7 0.0005
775 NEEDLE ISSUE 14 0.0005
776 NERVOUS SYSTEM DISORDER 15 0.0005
777 GASTROINTESTINAL DISORDER 43 0.0005
778 AGGRESSION 24 0.0005
779 GASTROINTESTINAL HAEMORRHAGE 40 0.0005
780 MUSCLE TWITCHING 11 0.0005
781 PRODUCT USE IN UNAPPROVED INDICATION 118 0.0005
782 UPPER GASTROINTESTINAL HAEMORRHAGE 8 0.0005
783 DERMATITIS ATOPIC 25 0.0005
784 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 11 0.0005
785 INJECTION SITE IRRITATION 6 0.0005
786 EXTRA DOSE ADMINISTERED 19 0.0005
787 COMPLETED SUICIDE 39 0.0005
788 MYDRIASIS 6 0.0005
789 GLAUCOMA 9 0.0005
790 ROTATOR CUFF SYNDROME 6 0.0005
791 BREAST CANCER METASTATIC 5 0.0005
792 ERUCTATION 9 0.0005
793 RASH GENERALISED 12 0.0005
794 CONTRAINDICATED PRODUCT ADMINISTERED 14 0.0005
795 LOCAL SWELLING 8 0.0005
796 DEVICE USE ISSUE 8 0.0005
797 INTERNATIONAL NORMALISED RATIO INCREASED 13 0.0005
798 LYMPHOMA 7 0.0005
799 HYPERHIDROSIS 58 0.0004
800 AGITATION 33 0.0004
801 THERAPY PARTIAL RESPONDER 7 0.0004
802 HAIR TEXTURE ABNORMAL 6 0.0004
803 QUALITY OF LIFE DECREASED 6 0.0004
804 GLOSSODYNIA 10 0.0004
805 PRODUCT TASTE ABNORMAL 6 0.0004
806 GINGIVAL BLEEDING 6 0.0004
807 OFF LABEL USE 383 0.0004
808 CARDIAC FAILURE 35 0.0004
809 GLYCOSYLATED HAEMOGLOBIN INCREASED 11 0.0004
810 ABDOMINAL PAIN LOWER 11 0.0004
811 HYPOMAGNESAEMIA 6 0.0004
812 HUNGER 6 0.0004
813 HAEMOPTYSIS 12 0.0004
814 URTICARIA 72 0.0004
815 HEPATIC STEATOSIS 8 0.0004
816 LUNG DISORDER 21 0.0004
817 ANAPHYLACTIC SHOCK 11 0.0004
818 DISCOMFORT 26 0.0004
819 HYPOXIA 15 0.0004
820 EPILEPSY 13 0.0004
821 CARDIAC ARREST 35 0.0004
822 ARRHYTHMIA 20 0.0004
823 PSYCHOMOTOR HYPERACTIVITY 7 0.0004
824 PULMONARY EMBOLISM 40 0.0004
825 INCORRECT DOSE ADMINISTERED 96 0.0004
826 COMA 20 0.0004
827 SKIN DISORDER 14 0.0004
828 CONVULSION 24 0.0004
829 LIVER FUNCTION TEST INCREASED 9 0.0004
830 ANGINA PECTORIS 12 0.0004
831 LOWER RESPIRATORY TRACT INFECTION 19 0.0004
832 EYE PRURITUS 14 0.0004
833 POST PROCEDURAL COMPLICATION 8 0.0004
834 SUICIDAL IDEATION 38 0.0004
835 DEVICE DISLOCATION 18 0.0004
836 THERAPEUTIC RESPONSE DECREASED 25 0.0004
837 PANCYTOPENIA 23 0.0004
838 CHOKING 8 0.0004
839 CARDIO-RESPIRATORY ARREST 17 0.0004
840 RENAL IMPAIRMENT 34 0.0004
841 DEVICE DEFECTIVE 7 0.0004
842 COLON CANCER 6 0.0004
843 LACTIC ACIDOSIS 13 0.0004
844 MYOCARDIAL INFARCTION 70 0.0004
845 RENAL FAILURE ACUTE 17 0.0004
846 PRODUCT USE ISSUE 75 0.0004
847 RESPIRATORY DISTRESS 11 0.0004
848 HYPOAESTHESIA ORAL 6 0.0004
849 RASH ERYTHEMATOUS 19 0.0004
850 BRAIN OEDEMA 5 0.0004
851 INJECTION SITE RASH 12 0.0004
852 ERECTILE DYSFUNCTION 10 0.0004
853 RHEUMATOID ARTHRITIS 44 0.0004
854 HAEMATOMA 10 0.0004
855 PHARMACEUTICAL PRODUCT COMPLAINT 10 0.0004
856 BASAL CELL CARCINOMA 6 0.0004
857 INJURY 27 0.0004
858 BLOOD CREATINE PHOSPHOKINASE INCREASED 11 0.0004
859 CYANOSIS 6 0.0004
860 MOUTH ULCERATION 8 0.0004
861 ASPARTATE AMINOTRANSFERASE INCREASED 20 0.0004
862 PSYCHOTIC DISORDER 11 0.0004
863 GENERAL PHYSICAL HEALTH DETERIORATION 43 0.0004
864 INJECTION SITE PAIN 113 0.0004
865 CEREBRAL INFARCTION 9 0.0004
866 PROTEINURIA 7 0.0004
867 SEPTIC SHOCK 16 0.0004
868 PRODUCT DISPENSING ERROR 8 0.0004
869 PNEUMONITIS 10 0.0004
870 ENCEPHALOPATHY 9 0.0004
871 INJECTION SITE SWELLING 28 0.0004
872 INTENTIONAL PRODUCT USE ISSUE 32 0.0004
873 LUNG NEOPLASM MALIGNANT 15 0.0004
874 HAEMORRHAGE 38 0.0004
875 RESPIRATORY ARREST 10 0.0004
876 VISUAL ACUITY REDUCED 12 0.0004
877 LEUKOPENIA 18 0.0004
878 DEPRESSED LEVEL OF CONSCIOUSNESS 14 0.0004
879 DRUG WITHDRAWAL SYNDROME 31 0.0004
880 NEUTROPENIA 48 0.0004
881 CIRCULATORY COLLAPSE 6 0.0004
882 INJECTION SITE REACTION 24 0.0003
883 ADVERSE EVENT 32 0.0003
884 PLEURAL EFFUSION 21 0.0003
885 NEUTROPHIL COUNT DECREASED 14 0.0003
886 INJECTION SITE PRURITUS 23 0.0003
887 ACUTE MYOCARDIAL INFARCTION 10 0.0003
888 SWELLING FACE 22 0.0003
889 THERAPEUTIC PRODUCT EFFECT DECREASED 15 0.0003
890 FEAR 9 0.0003
891 BLOOD GLUCOSE INCREASED 63 0.0003
892 THROAT TIGHTNESS 9 0.0003
893 PELVIC PAIN 6 0.0003
894 BONE DISORDER 6 0.0003
895 OSTEONECROSIS OF JAW 8 0.0003
896 PANCREATITIS 17 0.0003
897 DEATH 276 0.0003
898 MELAENA 7 0.0003
899 NEOPLASM PROGRESSION 11 0.0003
900 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
901 PULMONARY FIBROSIS 6 0.0003
902 METABOLIC ACIDOSIS 10 0.0003
903 DRUG PRESCRIBING ERROR 6 0.0003
904 RHABDOMYOLYSIS 13 0.0003
905 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 63 0.0003
906 LYMPHADENOPATHY 11 0.0003
907 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 17 0.0003
908 ALANINE AMINOTRANSFERASE INCREASED 19 0.0003
909 INJECTION SITE ERYTHEMA 38 0.0003
910 SEDATION 8 0.0003
911 SHOCK 7 0.0003
912 GASTRITIS 8 0.0003
913 TACHYCARDIA 27 0.0003
914 UNDERDOSE 22 0.0003
915 BREAST CANCER FEMALE 8 0.0003
916 INJECTION SITE MASS 11 0.0003
917 PAIN OF SKIN 8 0.0003
918 ANGER 10 0.0003
919 INJURY ASSOCIATED WITH DEVICE 6 0.0003
920 LIVER DISORDER 13 0.0003
921 MALIGNANT NEOPLASM PROGRESSION 30 0.0003
922 ANAPHYLACTIC REACTION 16 0.0003
923 HYPOGLYCAEMIA 14 0.0003
924 PRESYNCOPE 7 0.0003
925 WITHDRAWAL SYNDROME 12 0.0003
926 NEOPLASM MALIGNANT 19 0.0003
927 TARDIVE DYSKINESIA 8 0.0003
928 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
929 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
930 DRUG ABUSE 23 0.0003
931 HAEMATEMESIS 7 0.0003
932 CARDIOVASCULAR DISORDER 7 0.0003
933 PRODUCT PRESCRIBING ISSUE 6 0.0003
934 DRUG EFFECT INCOMPLETE 10 0.0003
935 C-REACTIVE PROTEIN INCREASED 10 0.0003
936 DEVICE MALFUNCTION 19 0.0003
937 MEDICATION ERROR 15 0.0003
938 RESPIRATORY FAILURE 19 0.0003
939 PALLOR 7 0.0003
940 PRODUCT PRESCRIBING ERROR 6 0.0003
941 CEREBRAL HAEMORRHAGE 9 0.0003
942 ELECTROCARDIOGRAM QT PROLONGED 9 0.0002
943 WRONG TECHNIQUE IN DRUG USAGE PROCESS 9 0.0002
944 PSORIATIC ARTHROPATHY 10 0.0002
945 DEVICE ISSUE 22 0.0002
946 DISEASE PROGRESSION 29 0.0002
947 INJECTION SITE URTICARIA 6 0.0002
948 LIVER INJURY 6 0.0002
949 OSTEONECROSIS 8 0.0002
950 PRODUCT SUBSTITUTION ISSUE 14 0.0002
951 HEPATITIS 6 0.0002
952 ACCIDENTAL EXPOSURE TO PRODUCT 24 0.0002
953 DEVICE USE ERROR 8 0.0002
954 DRUG ADMINISTRATION ERROR 7 0.0002
955 SYSTEMIC LUPUS ERYTHEMATOSUS 8 0.0002
956 BREAST CANCER 21 0.0002
957 SKIN BURNING SENSATION 16 0.0002
958 JAUNDICE 6 0.0002
959 PSORIASIS 29 0.0002
960 APPLICATION SITE PRURITUS 5 0.0002
961 EMOTIONAL DISTRESS 26 0.0002
962 EXPIRED PRODUCT ADMINISTERED 7 0.0002
963 VAGINAL HAEMORRHAGE 9 0.0002
964 TREATMENT FAILURE 17 0.0002
965 ANGIOEDEMA 9 0.0002
966 INTENTIONAL OVERDOSE 13 0.0002
967 INJECTION SITE HAEMORRHAGE 16 0.0002
968 SUICIDE ATTEMPT 12 0.0002
969 ACNE 15 0.0002
970 DEVICE BREAKAGE 8 0.0002
971 OVERDOSE 42 0.0002
972 EMOTIONAL DISORDER 6 0.0002
973 BONE DENSITY DECREASED 6 0.0002
974 INTERSTITIAL LUNG DISEASE 9 0.0002
975 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
976 TOXICITY TO VARIOUS AGENTS 29 0.0002
977 ASCITES 5 0.0002
978 INCORRECT ROUTE OF DRUG ADMINISTRATION 6 0.0002
979 DEVICE LEAKAGE 7 0.0002
980 DISEASE RECURRENCE 7 0.0001
981 DRUG DEPENDENCE 23 0.0001
982 PRODUCT STORAGE ERROR 12 0.0001
983 PROSTATE CANCER 11 0.0001
984 FEBRILE NEUTROPENIA 9 0.0001
985 PRODUCT QUALITY ISSUE 18 0.0001
986 SKIN IRRITATION 6 0.0001
987 NO ADVERSE EVENT 23 0.0001
988 ABORTION SPONTANEOUS 5 0.0001
989 DEVICE DIFFICULT TO USE 7 0.0001
990 BLADDER CANCER 6 0.0001
991 MATERNAL EXPOSURE DURING PREGNANCY 7 0.0001
992 DRUG DOSE OMISSION BY DEVICE 6 0.0001